Announcements Trials
Browse Landscape

Phase

Phase 2 159Phase 3 30Phase 1/2 16Phase 1 10Phase NA 7Phase 2/3 3Phase EARLY_PHASE1 2Phase 4 2

Status

Completed 13Recruiting 10Active not recruiting 5Unknown 3Terminated 3Not yet recruiting 3Withdrawn 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Oesophagogastric Cancer 1Disease Free Survival 1Colonic Neoplasms 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Bevacizumab × Clear all
NCT04138992 2020-06-30

A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer

Air Force Military Medical University, China

Phase 2/3 Unknown
150 enrolled

Disease Free Survival

NCT03686254 2018-09-26

The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
160 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown
1,103 enrolled
Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡